AJ Vaccines A/S

CVR 37911143 · Public limited company (A/S) · Active · Low risk

AJ Vaccines A/S is a Public limited company (A/S), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 10 annual reports have been published, of which 7 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 288.5m and a net result of DKK -483.4m.

Bankruptcy risk for AJ Vaccines A/S

0.1%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 38% of active Danish companies

Lowest riskHighest risk

Increases the risk

Share of late annual reports50%–75% · bankruptcy rate 18.4%2.1×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Reporting classReporting class C, large enterprise · bankruptcy rate 0.2%0.03×
Employees (latest year)100+ · bankruptcy rate 2.3%0.27×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
37911143
Status
Active
Company type
Public limited company (A/S)
Founded
(10 years)
Address
Artillerivej 5
2300 København S
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 106.6m
Employees
683 (2018)
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late7 of 10
Missing annual reportNo
Negative equityNo
Equity ratio33.5%
Current ratio193%
Moves (last 2 years)0
CEO changes in total7
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
RevenueDKK 389.7mDKK 413.0mDKK 468.9m
Gross profitDKK -220.3mDKK -587.0mDKK -30.7m
Net profitDKK -483.4mDKK -807.1mDKK -243.0m
EquityDKK 288.5mDKK 501.9mDKK 1.0bn
Total assetsDKK 861.2mDKK 1.1bnDKK 1.6bn
CashDKK 9.8mDKK 8.5m–
Short-term debtDKK 253.0mDKK 275.5m–
Avg. employees451581–

Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025195 Late
1 Jan 2024 – 31 Dec 2024189 Late
1 Jan 2023 – 31 Dec 2023190 Late
1 Jan 2022 – 31 Dec 2022192 Late
1 Jan 2021 – 31 Dec 2021190 Late
1 Jan 2020 – 31 Dec 2020201 Late
1 Jan 2019 – 31 Dec 2019248 Late
1 Jan 2018 – 31 Dec 2018154
1 Sep 2016 – 31 Dec 2017148
4 Aug 2016 – 31 Aug 201699

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOPia Birgitte Lading
CEOJesper Helmuth Larsen
CEOJerome Christian Roger Cabannes
CEOJérome Christian Roger Cabannes
BoardMustafa Nasir FarookiCurrent
BoardSaddam Abdulqawi Hussein AlhumaikaniCurrent
BoardMohammed Ali A AlesayiCurrent
BoardAbdulaziz Abdulhamid Abdulrhman AlbassamCurrent
BoardTarek Sherif Ahmed Abbas HegazyCurrent
BoardIvan Madsen
BoardPoul Jagd Mogensen
BoardHenrik Juul Hansen
BoardHelle Birk Krogsgaard
BoardMie Lund Buhl
BoardPia Birgitte Lading
BoardKlaus Hermansen
BoardTabassum Khan
BoardJesper Helmuth Larsen
BoardSaddam Abdulqawi Hussein Alhumaikani
BoardShan-E-Abbas Ashary
BoardAbdul Wahab Mohammed A Alesayi
BoardAbdulaziz Hamad Aljomaih
BoardShan-E-Abbas Ashary
BoardAbdulaziz Hamad Aljomaih
Owner (100%)AJ Vaccines Holding ApSCurrent
Owner (100%)ACCURA ADVOKATPARTNERSELSKAB
Owner (100%)Statens Serum Institut
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorEY Godkendt Revisionspartnerselskab
FounderACCURA ADVOKATPARTNERSELSKABCurrent

The CEOs' other companies

Jesper Helmuth Larsen – 16 other companies, of which 1 bankrupt

Address history (1 moves)

Artillerivej 5, 2300 København S
c/o Accura advokatpartnerselskab, Tuborg Boulevard 1, 2900 Hellerup

Former names

AJ Vaccines A/S – now
Aktieselskabet af august 2016 –

Employees per year

Number of employees at AJ Vaccines A/S per year3426832017: 62020172018: 6832018

Other companies at the same address

Similar companies in København

Questions and answers about AJ Vaccines A/S

Has AJ Vaccines A/S gone bankrupt?

No, AJ Vaccines A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of AJ Vaccines A/S?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the auditor of AJ Vaccines A/S?

AJ Vaccines A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was AJ Vaccines A/S founded?

AJ Vaccines A/S was founded on 4 August 2016.

What is the equity of AJ Vaccines A/S?

Equity was DKK 288.5m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.